(Q54385140)

29 May 2018

https://doi.org/10.1002/cncr.35092

1 reference

29 December 2023

title

Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells. (English)

1 reference

29 May 2018

endometrial adenocarcinoma

1 reference

1 reference

1 reference

Yanjing Wu

1

1 reference

29 May 2018

Shupeng Liu

2

1 reference

29 May 2018

Hong Xin

3

1 reference

29 May 2018

Jing Jiang

4

1 reference

29 May 2018

Edward Younglai

5

1 reference

29 May 2018

Shuhan Sun

6

1 reference

29 May 2018

Huilan Wang

7

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 March 2011

1 reference

29 May 2018

published in

Cancer

1 reference

29 May 2018

volume

117

1 reference

29 May 2018

issue

17

1 reference

29 May 2018

page(s)

3989-3998

1 reference

29 May 2018

Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation: a clinicopathologic study of 5 cases and review of the literature

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Building a framework for embryonic microenvironments and cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Reprogramming of human somatic cells to pluripotency with defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

A microRNA component of the p53 tumour suppressor network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

A mammalian microRNA expression atlas based on small RNA library sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Experimental identification of microRNA targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Glycodelin in reproductive endocrinology and hormone-related cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Identification of novel genes coding for small expressed RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

p53 represses c-Myc through induction of the tumor suppressor miR-145

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

Oct-3/4 is a dose-dependent oncogenic fate determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

inferred from DOI database lookup

7 January 2021

based on heuristic

Enhanced antitumor responses elicited by combinatorial protein transfer of chemotactic and costimulatory molecules

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25944

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.25944

1 reference

29 May 2018

PubMed ID

21365617

1 reference

29 May 2018